ANNALS OF CLINICAL BIOCHEMISTRY, vol.48, pp.45-50, 2011 (SCI-Expanded)
Background: Ischaemia-modified albumin (IMA) is a relatively new marker of ischaemia. IMA has not been studied previously in pleural effusions due to congestive heart failure (CHF). The aim of our study was to assess the diagnostic value of IMA in the pleural fluid (PF) and serum for the identification of pleural effusion due to CHF.